Editorial Policy & Standards
Peptides.NYC publishes educational health content. This page explains who writes that content, how it gets reviewed, and the important things we can't do for you.
Our Mission
Peptides.NYC exists to provide accurate, accessible education about peptide therapy and health optimization. We recognize this is a rapidly evolving field where misinformation can have real consequences.
Our goal is to be a trusted educational guide — not a sales pitch and not a clinical service. We do not sell peptides, and our content is not influenced by commercial relationships with vendors.
Content Principles
Content Review Process
Research & Drafting
Articles are researched and written by the editorial team. Primary sources are identified and cited inline or in a References section.
Editorial Review
The editorial team reviews each article for accuracy, clarity, and completeness. Claims are verified against cited sources before publication.
Publication & Monitoring
Content is published with a 'Last Updated' date. We monitor for new research, FDA actions, or state regulatory changes that may require revisions.
Sources & Citations
We prioritize high-quality sources including:
- Peer-reviewed research from journals indexed in PubMed, including randomized controlled trials and systematic reviews
- Clinical trial data from ClinicalTrials.gov and published trial results
- Regulatory documents from the FDA, DEA, and state medical boards
- Medical guidelines from professional organizations such as the Endocrine Society and the American Academy of Anti-Aging Medicine
We distinguish between established evidence and emerging research. When evidence is limited or preliminary, we say so explicitly.
Updates & Corrections
We are committed to keeping our content accurate and current. When we discover errors or when new research becomes available:
- Factual corrections are made promptly with a note indicating the correction
- Content updatesare noted with a "Last updated" date visible on each article
- Major revisions are noted in an update summary at the top of the article